CASSIE GUSTE: Open Payments
NPI 1063813681 · ROBERT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,095 in 37 payments from 18 companies in 2025. Trend: 2023 $2,762 · 2024 $2,865 · 2025 $1,095
Food & beverage: $1,006Education: $89
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $429 |
| Actelion Pharmaceuticals US, Inc. | 4 | $137 |
| Novo Nordisk Inc | 6 | $120 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| Lilly USA, LLC | 3 | $49 |
| PFIZER INC. | 2 | $44 |
| Boston Scientific Corporation | 1 | $26 |
| Edwards Lifesciences Corporation | 1 | $23 |
| Contego Medical, Inc | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: AIRSUPRA, OPSUMIT, Wegovy, SHINGRIX, MOUNJARO, BREZTRI, Ozempic, UPTRAVI.
Industry payments across LA — which companies pay providers there.
